# BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

> **NCT02783794** · PHASE2 · COMPLETED · sponsor: **Meabco A/S** · enrollment: 36 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **DRUG:** BP-C1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02783794
- **Lead sponsor:** Meabco A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-24
- **Primary completion:** 2014-02-28
- **Final completion:** 2014-02-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-10-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02783794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02783794, "BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02783794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*